• Q4 FY25 cash receipts of $2.1m, leading to positive operating cash inflow of $0.3m
• Q4 FY25 revenue (unaudited) of $2.0m (19% recurring), up 148% on Q3 FY25, +14% pcp
• Annual Recurring Revenue (ARR) of $1.9m at the end of Q4 FY25 (up 14% on Q3 FY25, +49% pcp)

Visionflex Group Limited (ASX:VFX), a leader in virtual healthcare technology, has issued its Appendix 4C and quarterly market update for the 3 months ending 30 June 2025. The company achieved strong commercial outcomes, successfully converting a maturing pipeline into new revenue, securing key strategic wins, and momentum with subscription renewals. Customer cash receipts totaled $2.1m in Q4 FY25, a 136% increase on the receipts collected in Q3 FY25, reflecting improved customer conversion, growing commercial momentum, and typical seasonality in contract execution and customer billing cycles. Driven by strong cash receipts, the company delivered positive operating cash flows of $0.3m for Q4 FY25, representing a significant improvement from the $0.9m operating cash outflow in Q3 FY25. Unaudited Q4 FY25 revenue was $2.0m, up 148% on Q3 FY25 and 14% on the prior corresponding period (pcp), with approximately 19% of Q4 FY25 revenue being recurring. ARR increased by 14% during the quarter to reach $1.9m, a 49% increase compared to Q4 FY24. This growth reflects both ARR from new customer wins and successful expansion within the existing customer base, including upgrades and renewals across key market segments. The company also secured several significant sale agreements during Q4 FY25, including a transformative Australian government-funded virtual nursing pilot with Amplar Health, a contract with a leading ASX mining company, and expanded implementations with Central and Eastern Sydney PHN and Healthy North Coast PHN.

Visionflex enters FY26 with a solid foundation, underpinned by ARR of $1.9m. The increasing adoption and referenceability of Visionflex's solutions across multiple key customer verticals continues to drive confidence in the conversion of multiple active trial sites into large-scale, multi-site contracts. Building on the momentum achieved in Q4 FY25, Visionflex is set to launch a new solution tailored specifically for the In-Home Care market in Q1 FY26, representing a significant new addressable market opportunity.